AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

Discover how wearable technology, AI diagnostics, and remote monitoring are reshaping heart health for individuals over 40 in ...

Apple has picked up another win in its legal battle with health tech firm AliveCor, this time over antitrust claims relating ...

The latest update on iRhythm Technologies trims the fair value estimate slightly from about US$221 to roughly US$219, even as long term revenue growth assumptions edge higher from around 17.10% to ...

Abstract: In the field of remote sensing image processing, remote sensing image object detection is a crucial undertaking. However, the existing object detection algorithms have a considerable number ...

While many people do feel symptoms—a rapid heartbeat, skipping a beat, dizziness, extreme shortness of breath—up to a third of those with AFib don’t realize they have it, either because they have no ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib. Abbott said it plans ...

Abstract: A two-layer analysis approach of the atrial fibrillation episode detection algorithm tested in the MIT-BIH atrial fibrillation database (MIT-BIH AFDB) is proposed in the paper. We use ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA(R) home sleep apnea test.